Antidote is a digital health company on a mission to accelerate medical research. In a world where 80% of clinical trials are delayed or closed due to a shortage of suitable participants, Antidote uses precision recruitment to match the right patients with the right trials, striking the right balance between technology and human touch to deliver high-quality patient engagement.
Market
Medical Research
Location
New York,
New York,
United States
Coinvestors
LBO France, Merck Global Health Innovation Fund, Octopus Ventures, Smedvig Capital